vs

Side-by-side financial comparison of Claros Mortgage Trust, Inc. (CMTG) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

Claros Mortgage Trust, Inc. is the larger business by last-quarter revenue ($46.7M vs $32.6M, roughly 1.4× RxSight, Inc.). RxSight, Inc. runs the higher net margin — -28.1% vs -468.9%, a 440.9% gap on every dollar of revenue. On growth, RxSight, Inc. posted the faster year-over-year revenue change (-18.9% vs -22.4%). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs -10.9%).

Claros Mortgage Trust, Inc. is a U.S.-based real estate investment trust that invests in diversified mortgage-related assets, including residential and commercial mortgage loans and mortgage-backed securities. It pursues stable, risk-adjusted long-term returns for shareholders via rigorous asset evaluation and active portfolio management.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

CMTG vs RXST — Head-to-Head

Bigger by revenue
CMTG
CMTG
1.4× larger
CMTG
$46.7M
$32.6M
RXST
Growing faster (revenue YoY)
RXST
RXST
+3.5% gap
RXST
-18.9%
-22.4%
CMTG
Higher net margin
RXST
RXST
440.9% more per $
RXST
-28.1%
-468.9%
CMTG
Faster 2-yr revenue CAGR
RXST
RXST
Annualised
RXST
5.1%
-10.9%
CMTG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CMTG
CMTG
RXST
RXST
Revenue
$46.7M
$32.6M
Net Profit
$-219.2M
$-9.2M
Gross Margin
77.5%
Operating Margin
-34.8%
Net Margin
-468.9%
-28.1%
Revenue YoY
-22.4%
-18.9%
Net Profit YoY
-117.7%
-54.1%
EPS (diluted)
$-1.56
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMTG
CMTG
RXST
RXST
Q4 25
$46.7M
$32.6M
Q3 25
$46.1M
$30.3M
Q2 25
$51.6M
$33.6M
Q1 25
$43.4M
$37.9M
Q4 24
$60.2M
$40.2M
Q3 24
$64.9M
$35.3M
Q2 24
$64.5M
$34.9M
Q1 24
$58.8M
$29.5M
Net Profit
CMTG
CMTG
RXST
RXST
Q4 25
$-219.2M
$-9.2M
Q3 25
$-9.5M
$-9.8M
Q2 25
$-181.7M
$-11.8M
Q1 25
$-78.6M
$-8.2M
Q4 24
$-100.7M
$-5.9M
Q3 24
$-56.2M
$-6.3M
Q2 24
$-11.6M
$-6.1M
Q1 24
$-52.8M
$-9.1M
Gross Margin
CMTG
CMTG
RXST
RXST
Q4 25
77.5%
Q3 25
79.9%
Q2 25
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
71.4%
Q2 24
69.5%
Q1 24
70.1%
Operating Margin
CMTG
CMTG
RXST
RXST
Q4 25
-34.8%
Q3 25
-40.1%
Q2 25
-41.6%
Q1 25
-28.2%
Q4 24
-21.5%
Q3 24
-26.1%
Q2 24
-23.9%
Q1 24
-36.2%
Net Margin
CMTG
CMTG
RXST
RXST
Q4 25
-468.9%
-28.1%
Q3 25
-20.7%
-32.4%
Q2 25
-351.9%
-35.0%
Q1 25
-181.3%
-21.6%
Q4 24
-167.2%
-14.8%
Q3 24
-86.7%
-17.9%
Q2 24
-17.9%
-17.4%
Q1 24
-89.7%
-30.8%
EPS (diluted)
CMTG
CMTG
RXST
RXST
Q4 25
$-1.56
$-0.22
Q3 25
$-0.07
$-0.24
Q2 25
$-1.30
$-0.29
Q1 25
$-0.56
$-0.20
Q4 24
$-0.72
$-0.14
Q3 24
$-0.40
$-0.16
Q2 24
$-0.09
$-0.16
Q1 24
$-0.39
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMTG
CMTG
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$173.2M
$228.1M
Total DebtLower is stronger
$3.2B
Stockholders' EquityBook value
$1.5B
$275.7M
Total Assets
$4.7B
$311.8M
Debt / EquityLower = less leverage
2.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMTG
CMTG
RXST
RXST
Q4 25
$173.2M
$228.1M
Q3 25
$339.5M
$227.5M
Q2 25
$209.2M
$227.5M
Q1 25
$127.8M
$229.3M
Q4 24
$99.1M
$237.2M
Q3 24
$113.9M
$237.1M
Q2 24
$148.2M
$233.3M
Q1 24
$232.5M
$125.4M
Total Debt
CMTG
CMTG
RXST
RXST
Q4 25
$3.2B
Q3 25
$3.7B
Q2 25
$4.0B
Q1 25
$4.7B
Q4 24
$4.9B
Q3 24
$5.1B
Q2 24
$5.3B
Q1 24
$5.5B
Stockholders' Equity
CMTG
CMTG
RXST
RXST
Q4 25
$1.5B
$275.7M
Q3 25
$1.7B
$276.0M
Q2 25
$1.8B
$278.0M
Q1 25
$1.9B
$279.3M
Q4 24
$2.0B
$281.2M
Q3 24
$2.1B
$277.3M
Q2 24
$2.2B
$275.2M
Q1 24
$2.2B
$163.9M
Total Assets
CMTG
CMTG
RXST
RXST
Q4 25
$4.7B
$311.8M
Q3 25
$5.4B
$308.5M
Q2 25
$5.8B
$309.0M
Q1 25
$6.7B
$313.0M
Q4 24
$7.0B
$318.6M
Q3 24
$7.3B
$310.5M
Q2 24
$7.6B
$305.5M
Q1 24
$7.8B
$183.2M
Debt / Equity
CMTG
CMTG
RXST
RXST
Q4 25
2.06×
Q3 25
2.09×
Q2 25
2.29×
Q1 25
2.42×
Q4 24
2.44×
Q3 24
2.44×
Q2 24
2.46×
Q1 24
2.47×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMTG
CMTG
RXST
RXST
Operating Cash FlowLast quarter
$-30.5M
$-1.1M
Free Cash FlowOCF − Capex
$-2.3M
FCF MarginFCF / Revenue
-6.9%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMTG
CMTG
RXST
RXST
Q4 25
$-30.5M
$-1.1M
Q3 25
$8.8M
$-1.2M
Q2 25
$-5.8M
$-4.4M
Q1 25
$-35.8M
$-8.8M
Q4 24
$84.5M
$-4.3M
Q3 24
$39.2M
$650.0K
Q2 24
$5.5M
$-4.0M
Q1 24
$21.5M
$-9.3M
Free Cash Flow
CMTG
CMTG
RXST
RXST
Q4 25
$-2.3M
Q3 25
$-1.8M
Q2 25
$-5.9M
Q1 25
$-9.4M
Q4 24
$-5.1M
Q3 24
$-453.0K
Q2 24
$-5.5M
Q1 24
$-11.3M
FCF Margin
CMTG
CMTG
RXST
RXST
Q4 25
-6.9%
Q3 25
-5.8%
Q2 25
-17.6%
Q1 25
-24.8%
Q4 24
-12.7%
Q3 24
-1.3%
Q2 24
-15.9%
Q1 24
-38.2%
Capex Intensity
CMTG
CMTG
RXST
RXST
Q4 25
3.5%
Q3 25
1.9%
Q2 25
4.6%
Q1 25
1.5%
Q4 24
2.1%
Q3 24
3.1%
Q2 24
4.4%
Q1 24
6.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMTG
CMTG

Real Estate Owned Portfolio$34.2M73%
Other$11.1M24%
Mixed Use Property Fixed Rents$1.4M3%

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons